| Dr Sandra Maritza Jara, MD | |
|
10034 Cypress Shadow Ave, Tampa, FL 33647-1858 | |
| (813) 994-2486 | |
| Not Available |
| Full Name | Dr Sandra Maritza Jara |
|---|---|
| Gender | Female |
| Speciality | Gastroenterology |
| Experience | 24 Years |
| Location | 10034 Cypress Shadow Ave, Tampa, Florida |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003905605 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RG0100X | Internal Medicine - Gastroenterology | ME88282 (Florida) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Naples Community Hospital | Naples, FL | Hospital |
| Physicians Regional Medical Center - Pine Ridge | Naples, FL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Gastroenterology Associates Of Southwest Florida Llc | 8628960937 | 30 |
News Archive
Pearl Therapeutics Inc., a privately held company developing clinically differentiated combination therapies for the treatment of highly prevalent chronic respiratory diseases, including chronic obstructive pulmonary disease (COPD), today announced a $69 million Series C financing. The financing round was led by Vatera Healthcare Partners and included existing investors, Clarus Ventures, New Leaf Venture Partners and 5AM Ventures.
GlycoMimetics, Inc., a clinical-stage biotechnology company developing a new class of glycobiology-based therapies for a broad range of indications, today announced the company has raised $38 million in its latest round of venture financing. New investor Genzyme Ventures joined returning investors New Enterprise Associates, The Novartis Venture Fund, Anthem Capital and Alliance Technology Ventures in the round.
Upstate Medical University has produced a public service announcement that calls attention to the importance of being tested for glaucoma, the second leading cause of blindness in the world, according to the World Health Organization.
New Johns Hopkins research suggests that critically ill patients receiving steroids in a hospital's intensive care unit (ICU) are significantly more likely to develop delirium. Results of their research, they say, suggest minimizing the use of steroids could reduce delirium in the ICU.
› Verified 8 days ago
| Entity Name | Gastroenterology Associates Of Southwest Florida Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1154304087 PECOS PAC ID: 8628960937 Enrollment ID: O20040329001722 |
News Archive
Pearl Therapeutics Inc., a privately held company developing clinically differentiated combination therapies for the treatment of highly prevalent chronic respiratory diseases, including chronic obstructive pulmonary disease (COPD), today announced a $69 million Series C financing. The financing round was led by Vatera Healthcare Partners and included existing investors, Clarus Ventures, New Leaf Venture Partners and 5AM Ventures.
GlycoMimetics, Inc., a clinical-stage biotechnology company developing a new class of glycobiology-based therapies for a broad range of indications, today announced the company has raised $38 million in its latest round of venture financing. New investor Genzyme Ventures joined returning investors New Enterprise Associates, The Novartis Venture Fund, Anthem Capital and Alliance Technology Ventures in the round.
Upstate Medical University has produced a public service announcement that calls attention to the importance of being tested for glaucoma, the second leading cause of blindness in the world, according to the World Health Organization.
New Johns Hopkins research suggests that critically ill patients receiving steroids in a hospital's intensive care unit (ICU) are significantly more likely to develop delirium. Results of their research, they say, suggest minimizing the use of steroids could reduce delirium in the ICU.
› Verified 8 days ago
| Entity Name | Gastroenterology Group Of Naples Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1912954694 PECOS PAC ID: 4789646209 Enrollment ID: O20041027001179 |
News Archive
Pearl Therapeutics Inc., a privately held company developing clinically differentiated combination therapies for the treatment of highly prevalent chronic respiratory diseases, including chronic obstructive pulmonary disease (COPD), today announced a $69 million Series C financing. The financing round was led by Vatera Healthcare Partners and included existing investors, Clarus Ventures, New Leaf Venture Partners and 5AM Ventures.
GlycoMimetics, Inc., a clinical-stage biotechnology company developing a new class of glycobiology-based therapies for a broad range of indications, today announced the company has raised $38 million in its latest round of venture financing. New investor Genzyme Ventures joined returning investors New Enterprise Associates, The Novartis Venture Fund, Anthem Capital and Alliance Technology Ventures in the round.
Upstate Medical University has produced a public service announcement that calls attention to the importance of being tested for glaucoma, the second leading cause of blindness in the world, according to the World Health Organization.
New Johns Hopkins research suggests that critically ill patients receiving steroids in a hospital's intensive care unit (ICU) are significantly more likely to develop delirium. Results of their research, they say, suggest minimizing the use of steroids could reduce delirium in the ICU.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Sandra Maritza Jara, MD 10034 Cypress Shadow Ave, Tampa, FL 33647-1858 Ph: (813) 994-2486 | Dr Sandra Maritza Jara, MD 10034 Cypress Shadow Ave, Tampa, FL 33647-1858 Ph: (813) 994-2486 |
News Archive
Pearl Therapeutics Inc., a privately held company developing clinically differentiated combination therapies for the treatment of highly prevalent chronic respiratory diseases, including chronic obstructive pulmonary disease (COPD), today announced a $69 million Series C financing. The financing round was led by Vatera Healthcare Partners and included existing investors, Clarus Ventures, New Leaf Venture Partners and 5AM Ventures.
GlycoMimetics, Inc., a clinical-stage biotechnology company developing a new class of glycobiology-based therapies for a broad range of indications, today announced the company has raised $38 million in its latest round of venture financing. New investor Genzyme Ventures joined returning investors New Enterprise Associates, The Novartis Venture Fund, Anthem Capital and Alliance Technology Ventures in the round.
Upstate Medical University has produced a public service announcement that calls attention to the importance of being tested for glaucoma, the second leading cause of blindness in the world, according to the World Health Organization.
New Johns Hopkins research suggests that critically ill patients receiving steroids in a hospital's intensive care unit (ICU) are significantly more likely to develop delirium. Results of their research, they say, suggest minimizing the use of steroids could reduce delirium in the ICU.
› Verified 8 days ago
Chhavi Gupta, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 508 S Habana Ave., Suite 270, Tampa, FL 33609 Phone: 813-388-1732 Fax: 813-864-9292 | |
Dr. Luis Leon Alvarado, MD Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 13000 Bruce B Downs Blvd, Va 111, Tampa, FL 33612 Phone: 813-972-2000 Fax: 813-631-3423 | |
Dr. Nirmal Shyam Sharma, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 2 Tampa General Cir Fl Circle6, Tampa, FL 33606 Phone: 813-974-2201 | |
Aniqa Shahrier, MD Gastroenterology Medicare: Medicare Enrolled Practice Location: 3003 W Dr Martin Luther King Jr Blvd Fl 3, Tampa, FL 33607 Phone: 877-537-4787 | |
Sriprintha Navarathinarajah, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 5130 Sunforest Dr Ste 300, Tampa, FL 33634 Phone: 727-824-0780 Fax: 813-514-8891 | |
Dr. Olga Kaliebe, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 2919 W Swann Ave, Tampa, FL 33609 Phone: 813-392-1900 Fax: 813-392-1901 | |
William Dinwoodie, MD Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 12902 Usf Magnolia Dr, Mdc 44, Tampa, FL 33612 Phone: 813-745-3980 Fax: 813-745-7229 |